Argatroban
Active substance: argatroban
INJECTION, SOLUTION · ARGATROBAN 100 mg/mL
United StatesActive
Marketing holder: Amneal Pharmaceuticals LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ARGATROBAN · 100 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-58d5-7b80-ae7e-e7ab245ae99f,01a1208c-597a-7d23-9a92-28c95c1a4bc9,01a1208d-82cf-7ee3-8414-8ff641cc30ea,01a1208d-8a41-7a2b-ad1d-65aef3ef5c6f,01a1208d-f0c3-74b1-85b6-0b60a33aaac2;count=17 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70121-1037
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 70121-1037 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70121-1037 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70121-1037 · Verified 2026-10-09 · open in source